Article
A stromal-state dichotomy governs recalcitrance or remission in inflammatory bowel disease
2026-05-06
Abstract excerpt
<h4>ABSTRACT</h4> Inflammatory bowel diseases (IBD) remain a relapsing, treatment-refractory disorder marked by progressive tissue injury and inflammation despite expanding immune-targeted therapies. We established a prospective cohort integrating stromal biobanking, functional phenotyping, cross-cohort benchmarking, and outcome modeling to define disease-anchored cellular states. Colonic myofibroblasts from 34 i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 15d970ba-ab1b-5e47-ae95-6fb2a024b4c5
- DOI
- 10.64898/2026.05.01.720931
